Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
Clinical trial NCT00049517 · COMPLETED
Trial details
- NCT number
- NCT00049517
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-12-19
- Primary completion
- 2009-03-01
- Enrollment
- 657
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.